BPC-157 5mg + TB-500 5mg (Blend)

BPC-157 5mg + TB-500 5mg (Blend)

BPC-157 5mg + TB-500 5mg
$120.00
Skip to product information
BPC-157 5mg + TB-500 5mg (Blend)

BPC-157 5mg + TB-500 5mg (Blend)

$120.00
SizeBPC-157 5mg + TB-500 5mg

Research Information

Better alternatives context The 10mg+10mg version lasts twice as long per vial. GLOW/KLOW blends add GHK-Cu (and KPV) but at lower BPC/TB doses per unit — better as a complement, not replacement.
Better alternatives context rt
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"The 10mg+10mg version lasts twice as long per vial. GLOW/KLOW blends add GHK-Cu (and KPV) but at lower BPC/TB doses per unit — better as a complement, not replacement."}]}]}
Body vs external supply 🟡 Natural/Topping Up
Brand trade names No pharmaceutical brand
Compounding pharmacy blend
Brand trade names rt
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"No pharmaceutical brand"}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Compounding pharmacy blend"}]}]}
Common side effects Combined: headache, flushing, mild GI. Generally well-tolerated.
Common side effects rt
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Combined: headache, flushing, mild GI. Generally well-tolerated."}]}]}
Contraindications do not combine • Avoid NSAIDs during use
• Avoid if active cancer/tumour history (angiogenesis concern)
Contraindications do not combine rt
{"type"=>"root", "children"=>[{"type"=>"list", "listType"=>"unordered", "children"=>[{"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"Avoid NSAIDs during use"}]}, {"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"Avoid if active cancer/tumour history (angiogenesis concern)"}]}]}]}
Delivery method SubQ injection
Drug interactions Unknown
Endogenous Natural/Topping Up
Fda status Category 2 (2023)
Full effect days 42
Half life ~4h / ~4-6h
Half life detail BPC: ~4hrs | TB-500: ~4-6hrs
Half life hours 5.0
Key studies references • No published studies on this specific combination
• Based on individual component research (see BPC-157 and TB-500 entries)
• NOT FDA APPROVED
Key studies references rt
{"type"=>"root", "children"=>[{"type"=>"list", "listType"=>"unordered", "children"=>[{"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"No published studies on this specific combination"}]}, {"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"Based on individual component research (see BPC-157 and TB-500 entries)"}]}, {"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"NOT FDA APPROVED"}]}]}]}
Known for
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"The standard healing stack pre-blended. Combines localised tissue repair (BPC) with systemic healing and cell migration (TB-500). Ideal for injury recovery, joint health, and faster return to training."}]}]}
Mechanism of action simplified Combined healing stack — BPC-157 (local, gut, tendon) + TB-500 (systemic, cardiac, anti-inflammatory). Complementary mechanisms.
Mechanism of action simplified rt
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Combined healing stack — BPC-157 (local, gut, tendon) + TB-500 (systemic, cardiac, anti-inflammatory). Complementary mechanisms."}]}]}
Onset days 5
Recommended vial size ★ 5mg+5mg per vial

At 10 units/day (2ml BAC) = ~10 days ✓. No shelf life issues.
Recommended vial size rt
{"type"=>"root", "children"=>[{"type"=>"list", "listType"=>"unordered", "children"=>[{"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"5mg+5mg per vial"}]}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"At 10 units/day (2ml BAC) = ~10 days ✓. No shelf life issues."}]}]}
Reversibility Fully reversible
Shelf life reconstituted 4–6 weeks
Storage lyophilised 2–8°C
Storage requirements Reconstituted: 2-8°C, 14-21 days
Subtitle Peptide blend · BPC-157 + Thymosin Beta-4 · Synthetic
Suppression None
Time to effects EARLY: 3-7 days
FULL: 4-8 weeks

Combines the fast onset of BPC-157 with the systemic healing of TB-500.

Day 3-7: Pain reduction and inflammation improvements (BPC effect).
Week 1-2: Healing acceleration noticeable.
Week 4-8: Major injury recovery. Flexibility improvements.

Minimum commitment: 4 weeks.
Time to effects rt
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"EARLY: ", "bold"=>true}, {"type"=>"text", "value"=>"3-7 days"}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"FULL: ", "bold"=>true}, {"type"=>"text", "value"=>"4-8 weeks"}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Combines the fast onset of BPC-157 with the systemic healing of TB-500."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Day 3-7: Pain reduction and inflammation improvements (BPC effect)."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Week 1-2: Healing acceleration noticeable."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Week 4-8: Major injury recovery. Flexibility improvements."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Minimum commitment: 4 weeks."}]}]}
Typical dosage 5-10 units daily with 2ml BAC water (250-500mcg of each per dose). SubQ near injury or abdominally.
Typical dosage rt
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"5-10 units daily with 2ml BAC water (250-500mcg of each per dose). SubQ near injury or abdominally."}]}]}
Typical dose short 250-500mcg
Vial duration At 10 units/day = ~10 days per vial.
Video references https://www.youtube.com/watch?v=HIrI8STJPJo, https://www.youtube.com/watch?v=gaQwrB8HW4o, https://www.youtube.com/watch?v=cNNuh2dLpDQ
Wada status Prohibited (S0)

You may also like